Sleep and Glucose Intolerance/Diabetes Mellitus

Sleep Medicine Clinics

Volumn 2, Issue 1, 2007, Pages 19-29

  Ip, Mary ^a   Mokhlesi, Babak ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXIA; LONGITUDINAL STUDY; NONHUMAN; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; POPULATION RESEARCH; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP TIME; WEIGHT GAIN;

EID: 34848909930     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2006.12.002     Document Type: Review

References (120)

1. Gavin III J.R., Alberti K.G.M.M., Davidson M.B., et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 1 (2005) S37-S42
3. Kahn C.R., and Saltiel A.R. The molecular mechanism of insulin action and the regulation of glucose and lipid metabolism. In: Kahn C.R. (Ed). Joslin's diabetes mellitus. 4th edition (2005), Lippincott Williams & Wilkins, Boston 145-168
4. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 26 2 (2005) 19-39
5. O'Rahilly S. Science, medicine, and the future. Non-insulin dependent diabetes mellitus: the gathering storm. BMJ 314 (1997) 955-959
6. World Health Organization. Diabetes mellitus: report of a WHO Study Group (1985), World Health Org, Geneva (Switzerland) [Technical Report Series No. 727]
7. Reaven G.M. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 47 4 (2005) 201-210
8. Eckel R., Grundy S., and Zimmet P. The metabolic syndrome. Lancet 365 9468 (2005) 1415-1428
9. WHO Consultation Group. Definition, diagnosis and classification of diabetes mellitus and its complications. In: Alberti K., and Zimmet P. (Eds). Part 1: diagnosis and classification of diabetes mellitus WHO/NCD/NCS/99. 2nd edition (1999), World Health Organization, Geneva (Switzerland) 1-59
10. National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) executive summary. 2001. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accessed December 2006.
11. Goutham R.A.O. Insulin resistance syndrome. Am Fam Physician 63 6 (2001) 1159-1163
12. Zimmet P., and Alberti K. The changing face of marcovascular disease in non-insulin dependent diabetes mellitus in different cultures: an epidemic in progress. Lancet 350 (1997) S1-S4
13. Sicree R., Shaw J.E., and Zimmer P.Z. The global burden of diabetes. In: Gan D. (Ed). Diabetes atlas. 2nd edition (2003), International Diabetes Federation, Brussels (Belgium) 15-71
14. Zimmet P., and Shaw J. Diabetes-a worldwide problem. In: Kahn R.C. (Ed). Joslin's diabetes mellitus. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 525-529
15. Van Cauter E., Polonsky K.S., and Scheen A.J. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 18 (1997) 716-738
16. Maquet P., Dive D., Salmon E., et al. Cerebral glucose utilization during stage 2 sleep in men. Brain Res 571 (1992) 149-153
17. Maquet P. Position omission tomography studies of sleep and sleep disorders. J Neurol 244 (1997) S23-S28
18. Van Cauter E., Blackman J.D., Roland D., et al. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 88 (1991) 934-942
19. National Sleep Foundation. "Sleep in America" poll (2002), National Sleep Foundation, Washington, DC
20. Jean-Louis G., Kripke D.F., and Ancoli-Israel S. Sleep and quality of well-being. Sleep 23 (2000) 1115-1121
21. National Center for Health Statistics. QuickStats: percentage of adults who reported an average of ≤ 6 hours of sleep per 24-hour period, by sex and age group-United States, 1985 and 2004. MMWR Morb Mortal Wkly Rep 54 MM37 (2005) 933
22. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
23. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6 (2002) 97-111
24. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 17 (1993) 1230-1235
25. Rechtschaffen A., Gilliland M.A., Bergmann B.M., et al. Physiological correlates of prolonged sleep deprivation in rats. Science 221 4606 (1983) 182-184
26. Rechtschaffen A., Bergmann B.M., Everson C.A., et al. Sleep deprivation in the rat: X. Integration and discussion of the findings. Sleep 12 (1989) 68-87
27. VanHelder T., Symons J.D., and Radomski M.W. Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med 64 (1993) 487-492
28. Spiegel K., Leproult R., L'Hermite-Baleriaux M., et al. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 89 (2004) 5762-5771
29. Kahn S.E., Prigeon R.L., McCulloch D.K., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42 (1993) 1663-1672
30. Catalano P.M., Tyzbir E.D., Wolfe R.R., et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264 (1993) E60-E67
31. Spiegel K., Tasali E., Penev P., et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141 11 (2004) 846-850
32. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
33. Spiegel K., Leproult R., Colecchia E.F., et al. Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am J Physiol Regul Integr Comp Physiol 279 (2000) R874-R883
34. Irwin M.R., Wang M., Campomayor C.O., et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166 (2006) 1756-1762
35. Festa A., D'Agostino Jr. R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
36. Vgontzas A.N., Zoumakis E., Bixler E.O., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89 (2004) 2119-2126
37. Knutson K, Spiegel K, Penev P, et al. Metabolic consequences of sleep deprivation. Sleep Med Rev, in press.
38. Gottlieb D.J., Punjabi N.M., Newman A.B., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165 (2005) 863-868
39. Ayas N.T., White D.P., Al-Delaimy W.K., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26 (2003) 380-384
40. Yaggi H.K., Araujo A.B., and McKinlay J.B. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29 3 (2006) 657-661
41. Mallon L., Browman J.E., and Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration; a 12-year follow-up study of a middle-aged population. Diabetes Care 28 (2005) 2762-2767
42. Bjorkelund C., Bondyr-Carlsson D., Lapidus L., et al. Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. Diabetes Care 28 (2005) 2739-2744
43. Nilsson P.M., Roost M., Engstrom G., et al. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 27 10 (2004) 2464-2469
44. Kawakami N., Takatsuka N., and Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27 (2004) 282-283
45. Meisinger C., Heier M., Loewel H., et al. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48 (2005) 235-241
46. Gislason T., and Almiqvist M. Somatic diseases and sleep complaints: an epidemiologic study of 3201 Swedish men. Acta Med Scand 221 (1987) 475-481
47. Hyyppa M.T., and Khronholm E. Quality of sleep and chronic illnesses. J Clin Epidemiol 42 (1989) 633-638
48. Sridhar G.R., and Madhu K. Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract 23 (1994) 183-186
49. Lamond N., Tiggemann M., and Dawson D. Facotrs predicting sleep disruption type II diabetes. Sleep 23 (2000) 415-416
50. Knutson K.L., Ryden A.M., Mander B.A., et al. Role of sleep duration and quality in the risk and severity of type II diabetes mellitus. Arch Intern Med 166 (2006) 1768-1774
51. Shigeta H., Shigeta M., Nakazawa A., et al. Lifestyle. Obesity and insulin resistance. Diabetes Care 24 3 (2001) 608
52. Sekine M., Yamagami T., Handa K., et al. A dose-response relationship between short sleeping hours and childhood obesity: results of the Toyama Birth Cohort Study. Child Care Health Dev 28 (2002) 163-170
53. Vorona R.D., Winn M.P., Babineau T.W., et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165 (2005) 25-30
54. Taheri S., Lin L., Austin D., et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1 3 (2004) 211-217
55. Young T., Peppard P., and Gottlieb D. Epidemiology of obstructive sleep apnea. A population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
56. Lam B., Lam D.C.L., and Ip M.S.M. Obstructive sleep apnea in Asia. Int J Tuberc Lung Dis 11 1 (2007) 2-11
57. Hiestand D.M., Britz P., Goldman M., et al. Prevalence of symptoms and risk of sleep apnea in the US population: results from the National Sleep Foundation Sleep in America 2005 poll. Chest 130 3 (2006) 780-786
58. Jennum P., Schultz-Larsen K., and Christensen N. Snoring sympathetic activity and cardiovascular risk factors in a 70 year old population. Eur J Epidemiol 9 (1993) 477-482
59. Grunstein R.R., Stenlof K., Hedner J., et al. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish obese subjects (SOS) study. Int J Obes Relat Metab Disord 19 (1995) 410-418
60. Enright P.L., Newman A.B., Wahl P.W., et al. Prevalence and correlates of snoring and observed apneas in 5201 older adults. Sleep 19 (1996) 531-538
61. Renko A.K., Hiltunen L., Laakso M., et al. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 67 (2005) 84-91
62. Shin C., Kim J., Kim J., et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 171 3 (2005) 287-291
63. Elmasry A., Lindberg E., Berne C., et al. Sleep-disordered breathing and glucose metabolism in hypertensive men, a population-based study. J Intern Med 249 (2001) 153-161
64. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 (2002) 677-682
65. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 6 (2004) 521-530
66. Resnick H.E., Redline S., Shahar E., et al. Diabetes and sleep disturbances. Diabetes Care 26 (2003) 702-709
67. Punjabi N.M., Ahmed M.M., Polotsky V.Y., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136 (2003) 167-178
68. Punjabi N.M., and Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99 (2005) 1998-2007
69. Tiihonen M., Partinen M., and Narvanen S. The severity of obstructive sleep apnoea is associated with insuin resistance. J Sleep Res 2 (1993) 56-61
70. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
71. Davies R.J.O., Turner R., Crosby J., et al. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment. J Sleep Res 3 (1994) 180-185
72. Stoohs R.A., Facchini F., and Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154 (1996) 170-174
73. Strohl K.P., Novak R.D., Singer W., et al. Insulin levels, blood pressure and sleep apnea. Sleep 17 (1994) 614-618
74. Ip M.S.M., Lam B., Ng M.M.T., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670-676
75. Tassone F., Lanfranco F., Gianotti L., et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol 59 (2003) 374-379
76. Sasanabe R., Katsuhisa B., Otake K., et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 29 (2006) 315-322
77. Coughlin S.R., Mawdsley L., Mugarza J.A., et al. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
78. West S.D., Nicoll D.J., and Stradling J.R. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61 11 (2006) 945-950
79. de la Eva R.C., Baur L.A., Donaghue K.C., et al. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 140 (2002) 654-659
80. Tauman R., O'Brien L.M., Ivanenko A., et al. Obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 116 1 (2005) e66-e73
81. Kaditis A.G., Alexopoulos E.I., Damani E., et al. Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol 40 6 (2005) 515-523
82. Elmasry A., Janson C., Lindberg E., et al. The role of habitual snoring and obesity in the development of diabetes, a 10-year follow-up study in a male population. J Intern Med 248 (2000) 13-20
83. Al-Delaimy W.K., Manson J.E., Willett W.C., et al. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 55 (2002) 387-393
84. Reichmuth K.J., Austin D., Skatrud J.B., et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172 12 (2005) 1590-1595
85. Brooks B., Cistulli P.A., Borkman M., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79 (1994) 1681-1685
86. Chin K., Nakamuta T., Takahashi K., et al. Effects of obstructive sleep apnea syndrome on serum amiotransfease levels in obese patients. Am J Med 114 5 (2003) 370-376
87. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999;100:706-12.
88. Cooper B.G., White J.E., Ashworth L.A., et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 (1995) 172-179
89. Saarelainen S., Lahtela J., and Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6 (1997) 146-147
90. Saini J., Krieger J., Brandenberger G., et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25 (1993) 375-381
91. Smurra M., Philip P., Thaillard J., et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2 (2001) 207-213
92. Stoohs R.A., Facchini F.S., Phillp P., et al. Selected cardiovascular risk factors in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure (n-CPAP). Sleep 16 (1993) S141-S142
93. Harsch I.A., Schahin S.P., Radespiel-Troger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 (2004) 156-162
94. Babu A.R., Herdegen J., Fogelfeld L., et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165 4 (2005) 447-452
95. Hassaballa H.A., Tulaimat A., Herdegen J.J., et al. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 9 (2005) 176-180
96. Lindberg E., Berne C., Elmasry A., et al. CPAP treatment of a population-based sample-what are the benefits and the treatment compliance?. Sleep Med 7 (2006) 553-560
97. West S.D., Nicoll D.J., Wallace T.M., et al. Obstructive sleep apnoea in men with type 2 diabetes: a double blind randomized controlled trial of the effects of CPAP on HbA1c and insulin resistance. Proc Amer Thor Soc 3 (2006) A733
98. Spiegel K., Knutson K., Leproult R., et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99 (2005) 2008-2019
99. Somers V.K., and Narkiewicz K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177 3 (2003) 385-390
100. Dimsdale J.E., Coy T., Ziegler M.G., et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18 5 (1995) 377-381
101. Marrone O., Riccobono L., Salvaggio A., et al. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103 (1993) 722-727
102. Leuenberger U., Jacob E., Sweer L., et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79 2 (1995) 581-588
103. Lam J.C.M., Tam S., Ooi C.G., et al. Relationship between sympathetic activity, obesity, and obstructive sleep apnea. Sleep Med 7 Suppl 2 (2006) S51
104. Parlapiano C., Borgia M.C., Minni A., et al. Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 31 4 (2005) 371-374
105. Grunstein R.R., Handelsman D.J., Lawrence S.J., et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 68 2 (1989) 352-358
106. Sandhu M.S., Heald A.H., Gibson J.M., et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359 (2002) 1740-1745
107. Polotsky V.Y., Li J., Punjabi N.M., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552 1 (2003) 253-264
108. Philips B.G., Kato M., Narkiewicz K., et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279 1 (2000) H234-H237
109. Ip M.S.M., Lam K.S.L., Ho C.M., et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 (2000) 580-586
110. Schafer H., Pauleit D., Sudhop T., et al. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122 (2002) 829-839
111. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 17 (2005) 2660-2667
112. Nourooz-Zadeh J., Rahimi A., Tajaddini-Sarmadi J., et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40 (1997) 647-653
113. Lavie L. Obstructive sleep apnea syndrome-an oxidative stress disorder. Sleep Med Rev 7 1 (2003) 33-51
114. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 (2002) 934-939
115. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymophonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 (2000) 566-570
116. Svatikova A., Wolk R., Lerman L.O., et al. Oxidative stress in obstructive sleep apnea. Eur Heart J 26 22 (2005) 2435-2439
117. Vgontzas A.N., Legro R.S., Bixler E.O., et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 2 5 (1997) 1313-1316
118. Vgontzas A.N., Bixler E.O., and Chrousos G.P. Metabolic disturbances in obesity versus sleep apnea: the importance of visceral obesity and insulin resistance. J Intern Med 254 1 (2003) 32-44
119. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
120. Bastard J.P., Maachi M., Tran Van Nheiu J., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol metab 87 (2002) 2084-2089